Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states

Abstract

Prostate cancer is the second most common malignancy in men worldwide and consists of a mixture of tumor and non-tumor cell types. To characterize the prostate cancer tumor microenvironment, we perform single-cell RNA-sequencing on prostate biopsies, prostatectomy specimens, and patient-derived organoids from localized prostate cancer patients. We uncover heterogeneous cellular states in prostate epithelial cells marked by high androgen signaling states that are enriched in prostate cancer and identify a population of tumor-associated club cells that may be associated with prostate carcinogenesis. ERG -negative tumor cells, compared to ERG -positive cells, demonstrate shared heterogeneity with surrounding luminal epithelial cells and appear to give rise to common tumor microenvironment responses. Finally, we show that prostate epithelial organoids harbor tumor-associated epithelial cell states and are enriched with distinct cell types and states from their parent tissues. Our results provide diagnostically relevant insights and advance our understanding of the cellular states associated with prostate carcinogenesis.

References 103

1. 1.

   Tiwari, R., Manzar, N. & Ateeq, B. Dynamics of cellular plasticity in prostate cancer progression. Front. Mol. Biosci. 7, 130 (2020).

   Not in our library10.3389/fmolb.2020.00130

2. 2.

   Blau HM, et al. Plasticity of the differentiated state. Science. 1985;230:758-766.

   Not in our library10.1126/science.2414846

3. 3.

   Yuan S, Norgard RJ, Stanger BZ. Cellular plasticity in cancer. Cancer Discov. 2019;9:837-851.

   Not in our library10.1158/2159-8290.cd-19-0015

4. 4.

   Varga J, Greten FR. Cell plasticity in epithelial homeostasis and tumorigenesis. Nat. Cell Biol. 2017;19:1133-1141.

   Not in our library10.1038/ncb3611

5. 5.

   Boutros PC, et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat. Genet. 2015;47:736-745.

   Not in our library10.1038/ng.3315

6. 6.

   Cooper CS, et al. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat. Genet. 2015;47:367-372.

   Not in our library10.1038/ng.3221

7. 7.

   DeMarzo AM, Nelson WG, Isaacs WB, Epstein JI. Pathological and molecular aspects of prostate cancer. Lancet. 2003;361:955-964.

   Not in our library10.1016/s0140-6736(03)12779-1

8. 8.

   Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev. 2010;24:1967-2000.

   Not in our library10.1101/gad.1965810

9. 9.

   Henry GH, et al. A cellular anatomy of the normal adult human prostate and prostatic urethra. Cell Rep. 2018;25:3530-3542.e5.

   Not in our library10.1016/j.celrep.2018.11.086

10. 10.

    Tomlins SA, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644-648.

    Not in our library10.1126/science.1117679

11. 11.

    Bhatia V, Ateeq B. Molecular underpinnings governing genetic complexity of ETS-fusion-negative prostate cancer. Trends Mol. Med. 2019;25:1024-1038.

    Not in our library10.1016/j.molmed.2019.07.001

12. 12.

    Abeshouse A, et al. The molecular taxonomy of primary prostate cancer. Cell. 2015;163:1011-1025.

    Not in our library10.1016/j.cell.2015.10.025

13. 13.
    Second-Strand Synthesis-Based Massively Parallel scRNA-Seq Reveals Cellular States and Molecular Features of Human Inflammatory Skin Pathologies · 2020

    No notice
14. 14.

    Tirosh I, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352:189-196.

    Not in our library10.1126/science.aad0501

15. 15.

    Zilionis R, et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity. 2019;50:1317-1334.e10.

    Not in our library10.1016/j.immuni.2019.03.009

16. 16.
    Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases · 2019

    No notice
17. 17.
    Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway · 2018

    No notice
18. 18.

    Hadadi, E. et al. Differential IL-1β secretion by monocyte subsets is regulated by Hsp27 through modulating mRNA stability. Sci. Rep. 6, 1–13 (2016).

    Not in our library10.1038/srep39035

19. 19.

    Aran D, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 2019;20:163-172.

    Not in our library10.1038/s41590-018-0276-y

20. 20.

    Stuart T, et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888-1902.e21.

    Not in our library10.1016/j.cell.2019.05.031

21. 21.

    Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 2018;36:411-420.

    Not in our library10.1038/nbt.4096

22. 22.

    Yue X, et al. Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma. Hepatology. 2017;65:1948-1962.

    Not in our library10.1002/hep.29036

23. 23.

    Zhang Q, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene. 2017;36:687-699.

    Not in our library10.1038/onc.2016.240

24. 24.

    Fotiou K, et al. Serum ceruloplasmin as a marker in prostate cancer. Minerva Urol. E Nefrol. Ital. J. Urol. Nephrol. 2007;59:407-411.

    Not in our library

25. 25.

    Abeshouse, A. et al. The molecular taxonomy of primary prostate cancer. Cell163, 1011–1025 (2015).

    Not in our library10.1016/j.cell.2015.10.025

26. 26.

    Setlur SR, et al. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J. Natl Cancer Inst. 2008;100:815-825.

    Not in our library10.1093/jnci/djn150

27. 27.
    Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods · 2019

    No notice
28. 28.

    Qian, X. et al. Spondin-2 (SPON2), a more prostate-cancer-specific diagnostic biomarker. PLoS ONE7, e37225 (2012).

    Not in our library10.1371/journal.pone.0037225

29. 29.

    Kenny PA. InferCNV, a python web app for copy number inference from discrete gene-level amplification signals noted in clinical tumor profiling reports. F1000Research. 2019;8:807.

    Not in our library10.12688/f1000research.19541.1

30. 30.

    Ellis L, Loda M. Advanced neuroendocrine prostate tumors regress to stemness. Proc. Natl Acad. Sci. USA. 2015;112:14406-14407.

    Not in our library10.1073/pnas.1519151112

31. 31.

    Goto K, et al. Proximal prostatic stem cells are programmed to regenerate a proximal-distal ductal axis. Stem Cells. 2006;24:1859-1868.

    Not in our library10.1634/stemcells.2005-0585

32. 32.

    Tsujimura A, et al. Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J. Cell Biol. 2002;157:1257-1265.

    Not in our library10.1083/jcb.200202067

33. 33.
    Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer · 1998

    Not checked
34. 34.

    Montoro DT, et al. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature. 2018;560:319-324.

    Not in our library10.1038/s41586-018-0393-7

35. 35.

    Thorek DL, Evans MJ, Carlsson SV, Ulmert D, Lilja H. Prostate specific kallikrein-related peptidases and their relation to prostate cancer biology and detection; established relevance and emerging roles. Thromb. Haemost. 2013;110:484-492.

    Not in our library10.1160/th13-04-0275

36. 36.

    Hessels D, Schalken JA. Urinary biomarkers for prostate cancer: a review. Asian J. Androl. 2013;15:333-339.

    Not in our library10.1038/aja.2013.6

37. 37.

    Zhang L, Barritt GJ. TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function? Endocr. Relat. Cancer. 2006;13:27-38.

    Not in our library10.1677/erc.1.01093

38. 38.

    Smith BA, et al. A human adult stem cell signature marks aggressive variants across epithelial cancers. Cell Rep. 2018;24:3353-3366.e5.

    Not in our library10.1016/j.celrep.2018.08.062

39. 39.

    Guo W, et al. Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips. Nat. Genet. 2020;52:908-918.

    Not in our library10.1038/s41588-020-0642-1

40. 40.

    Gurioli G, et al. Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. J. Transl. Med. 2016;14:249.

    Not in our library10.1186/s12967-016-1014-6

Cited by papers we hold 4

• Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses · 2023
  No notice
• Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance · 2023
  No notice
• Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease · 2022
  No notice
• Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance · 2022
  Corrected

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.